Abstract 73P
Background
Tumor infiltration by nerves and axial bone metastases often occur in prostate cancer (PCa) patients, however the mechanisms and the link between these processes are not well understood. Here, we report a PCa mouse model, which recapitulates this cancer route of spreading and correlates with radiological images from PCa patients.
Methods
The human androgen-independent PC3-ML cell line with reported bone metastasis potential was orthotopically injected into the prostate of SCID/Bg mice to observe the natural history of cancer spread instead of commonly used intratibial or intracardiac injections. The process of primary and secondary tumor development was monitored by magnetic resonance imaging (MRI). The tissues were collected and immunostained for neuronal markers, neurofilament (NF), and tyrosine hydroxylase (TH), as well as prostate cancer cell marker, pan-cytokeratin, and a vascular marker, CD31. Additionally, clinical cases of patients with representative MRI images of bone metastases and PNI were selected.
Results
The mice MRI revealed the presence of primary prostate tumor with secondary tumors located mostly along the lumbar spinal cord and pelvis, which led to secondary bone infiltration. The histopathological analysis confirmed the presence of PCa cells along the spine with its infiltration. The PCa cells created clusters, which spread along the small, NF-positive nerve fibers that were directed into the bone area. We ruled out the retrograde vessel infiltration by CD31 immunostaining. The clinical relevance of our model was confirmed by the radiological presentation of human PCa cases: 1) a patient with castration-sensitive PCa, with oligometastatic disease (one sacrum metastasis) and infiltration of neurovascular bundle; 2) a patient with castration-resistant PCa with PNI and a relapse in the ilium, who subsequently developed perispinal metastases along the lumbar plexus and spine.
Conclusions
Altogether, the results of our study suggest that PNI may be responsible for the initial PCa dissemination to bone. MRI imaging has adequate sensitivity to detect the nerve infiltration, however it is not commonly used in disseminated PCa patients. Consequently, the number of cases with spine infiltration and bone metastases may be underreported.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
Georgetown University Medical Center.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
67P - The effect of non-viral gene-immune therapy via OX40L or 4-1BBL on murine subcutaneous CT26 colon cancer model
Presenter: Olga Rakitina
Session: Poster session 09
68P - Dendritic polylysine with paclitaxel and triptolide codelivery for enhanced NSCLC ferroptosis through the accumulation of ROS
Presenter: Huae Xu
Session: Poster session 09
69P - Novel monoclonal antibodies can distinguish Cripto-1 from Cripto-3 proteins: Clinical implications and potential new biomarkers
Presenter: Josune Garcia-Sanmartin
Session: Poster session 09
70P - The human intratumor mycobiome is significantly influenced by an individual's race
Presenter: Dan Coster
Session: Poster session 09
71P - Preclinical characterization of ARX305: A next-generation anti-CD70 antibody drug conjugate for the treatment of CD70-expressing cancers
Presenter: Lillian Skidmore
Session: Poster session 09
72P - Impact of extended panel of genes for germline cancer testing
Presenter: Shaheenah Dawood
Session: Poster session 09
74P - Characterization of ERBB2 variation and their association with immune response in solid tumours
Presenter: Dong Wang
Session: Poster session 09
75P - Double-stranded RNA transfection induced anti-tumour effect mediated by dual RIG-I and TLR-3 immune pathways
Presenter: Jiayu Tai
Session: Poster session 09
76P - Improvement of whole-cell cancer vaccine anti-tumor effect by different injection methods
Presenter: Chin yang Chang
Session: Poster session 09
77P - Normative data on the sexual health questionnaires - QLQ-SHQ22, and the sexual domains of the QLQ-BR23/BR45 - for Norwegian general population with and without cancer
Presenter: Ragnhild Åsberg
Session: Poster session 09